Primary Objective: To estimate overall survival.~Secondary Objectives~To estimate progression-free survival.~To evaluate safety and tolerability in this patient population.~To evaluate the effect on levels of alpha-fetoprotein.
The primary goal of this study is to gather efficacy data concerning overall survival with electromagnetic field when compared to a placebo amplitude-modulated radiofrequency electromagnetic field device in subjects who have failed or are intolerant to at least two previous systemic therapies